Patents and pharmaceuticals - how does it work and how should it?

Nowadays, patenting and protecting patent rights for inventions in the field of pharmaceuticals are among the most topical issues, which cause lively debate in professional circles, since the patent is practically a legitimate monopoly, which to a certain extent contradicts the needs of society for affordable medicines. It is vital to determine the legal limits of what is permissible both for investors (patent holders) and for generics that usually provide the relevant affordability of the medicines in question. In this simplified representation scheme of the «originator - generic» relationship, no «good» or «bad» party might be distinguished, since only the balance of their legal capabilities would allow the society to receive proper development of pharmaceuticals.

Pressing issues related to the patenting of medicines, both from the point of view of originators and from the point of view of generics, will be discussed on February 7 - 8, 2022 at the Distant & Digital conference within the framework of the partner session of «A.Zalesov & Partners» Patent & Law Firm «Patent disputes in Pharma: a letter of the law vs extreme necessity».

The specialists of «A.Zalesov & Partners» Patent & Law Firm have an extensive experience in the field of patenting medicines, developing and protecting the patent portfolio of pharmaceutical companies, as well as representing the interests of clients - large multinational and Russian companies - in patent disputes.

The firm as a whole, as well as its partners are ranked and recommended by the respected international legal and industry rankings - IAM Patent 1000, WTR 1000, Chambers, Leaders League, IP Stars.

One of the projects that the firm’s partners develop is informing the widest possible audience about intellectual property issues. Patent attorneys of «A.Zalesov & Partners» contribute to different editions in various fields of intellectual property.

In addition, the company has launched its YouTube channel to highlight current intellectual property issues for both beginners and professionals.